Report overview
Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells.
This report contains market size and forecasts of Dendritic Cell Cancer Vaccine in global, including the following market information:
Global Dendritic Cell Cancer Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Dendritic Cell Cancer Vaccine Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Dendritic Cell Cancer Vaccine companies in 2021 (%)
The global Dendritic Cell Cancer Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CreaVax Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dendritic Cell Cancer Vaccine include Activarti, Argos Therapeutics, SOTIO (Acquired by PPF Group), Bellicum Pharmaceuticals, JW CreaGene, DanDrit, DCPrime, Elios Therapeutics and ImmunoCellular Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dendritic Cell Cancer Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dendritic Cell Cancer Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Dendritic Cell Cancer Vaccine Market Segment Percentages, by Type, 2021 (%)
CreaVax
Sipuleucel-T (Provenge)
Others
Global Dendritic Cell Cancer Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Dendritic Cell Cancer Vaccine Market Segment Percentages, by Application, 2021 (%)
Pediatrics
Adults
Global Dendritic Cell Cancer Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Dendritic Cell Cancer Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dendritic Cell Cancer Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Dendritic Cell Cancer Vaccine revenues share in global market, 2021 (%)
Key companies Dendritic Cell Cancer Vaccine sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Dendritic Cell Cancer Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Activarti
Argos Therapeutics
SOTIO (Acquired by PPF Group)
Bellicum Pharmaceuticals
JW CreaGene
DanDrit
DCPrime
Elios Therapeutics
ImmunoCellular Therapeutics
Kiromic
Medigene
Merck
Northwest Biotherapeutics
Immutep Limited
Dendreon Corporation
Oncobiomed
